 The effectiveness of β2-agonists in the treatment of exacerbations of COPD is already established. The purpose of this study is to compare the effectiveness of the β2-agonists alone in nebulization with the association β2-agonists Ipratropium bromide in the treatment of an acute exacerbation of COPD consulting the emergency departement based on the clinical and the aarterial blood gas. 